Stay updated on PEMBRO-RT in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the PEMBRO-RT in Advanced NSCLC Clinical Trial page.

Latest updates to the PEMBRO-RT in Advanced NSCLC Clinical Trial page
- CheckyesterdayChange DetectedThe clinical trial record is now displayed instead of an error page, with details about the pembrolizumab and SBRT study, its participants and treatment arms, measured outcomes, investigators, and related publications.SummaryDifference50%

- Check8 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0 while the study record page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedA sitewide NIH notice about the terminology shift from “artificial intelligence” to “super intelligence” appears above the unavailable study record.SummaryDifference1%

- Check22 days agoChange DetectedThe footer revision identifier advances from v3.7.1 to v3.7.2 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check29 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page now displays a 403 Forbidden error page with the site header/footer and a Home link plus a revision notice, indicating access to the study record is blocked rather than providing study content.SummaryDifference18%

Stay in the know with updates to PEMBRO-RT in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PEMBRO-RT in Advanced NSCLC Clinical Trial page.